Scotts Miracle Gro Analyst Price Targets - Benzinga

The Scotts Miracle Gro Co

SMGNYSE

Trade with Public

Trade with Public

$60.43

-0.16-0.26%

가까이에: Aug 28, 5:00 PM EST

$60.43

N/A

시간외: Aug 28, 4:00 PM EST

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

Scotts Miracle Gro Analyst Price Targets

Wall Street analyst price targets and consensus rating for Scotts Miracle Gro (SMG).

Price Target Range — 13 Quarters

Analyst Consensus — 7 Analysts

4Buy

3Hold

Consensus RatingBuy# Analysts7Avg. Consensus PT$73Upside to Avg. PT+21.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 3, 2026	Stifel	W. Andrew Carter	PT Raise	Buy	$75→$76
Jul 30, 2026	UBS	Peter Grom	PT Raise	Neutral	$70→$78
Jul 30, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$74→$77
Jul 16, 2026	UBS	Peter Grom	PT Raise	Neutral	$63→$70
Jul 8, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$72→$74
Jun 8, 2026	Stifel	W. Andrew Carter	PT Cut	Buy	$76→$75
Apr 8, 2026	Wells Fargo	Chris Carey	PT Cut	Overweight	$75→$72
Mar 26, 2026	JP Morgan	Jeffrey Zekauskas	Downgrade	Overweight→Neutral	$70→$67
Mar 3, 2026	Stifel	W. Andrew Carter	PT Raise	Buy	$70→$79
Jan 29, 2026	Wells Fargo	Chris Carey	PT Raise	Overweight	$67→$70
Jan 14, 2026	UBS	Peter Grom	PT Raise	Neutral	$61→$66
Nov 6, 2025	UBS	Peter Grom	PT Cut	Neutral	$62→$61
Nov 6, 2025	Stifel	W. Andrew Carter	Upgrade	Hold→Buy	$70
Nov 5, 2025	Jefferies	Jonathan Matuszewski	PT Raise	Buy	$71→$74
Oct 2, 2025	UBS	Peter Grom	PT Cut	Neutral	$68→$62
Sep 25, 2025	Wells Fargo	Chris Carey	PT Cut	Overweight	$75→$67
Aug 4, 2025	Stifel	W. Andrew Carter	PT Cut	Hold	$71→$70
Jul 31, 2025	UBS	Peter Grom	PT Cut	Neutral	$71→$68
Jul 17, 2025	UBS	Peter Grom	PT Raise	Neutral	$54→$71
Jul 14, 2025	Truist Securities	Bill Chappell	PT Raise	Buy	$75→$80

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Stifel Maintains Buy on Scotts Miracle Gro, Raises Price Target to $76

Stifel analyst W. Andrew Carter maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and raises the price target from $75 to $76.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Scotts Miracle Gro, Raises Price Target to $78

UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $70 to $78.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Scotts Miracle Gro, Raises Price Target to $77

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and raises the price target from $74 to $77.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Scotts Miracle Gro, Raises Price Target to $70

UBS analyst Peter Grom maintains Scotts Miracle Gro (NYSE:SMG) with a Neutral and raises the price target from $63 to $70.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Scotts Miracle Gro, Raises Price Target to $74

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and raises the price target from $72 to $74.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Scotts Miracle Gro, Lowers Price Target to $75

Stifel analyst W. Andrew Carter maintains Scotts Miracle Gro (NYSE:SMG) with a Buy and lowers the price target from $76 to $75.

Benzinga Newsdesk